Pegloprastide Publications
- Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study
Ann Surg Oncol. – October 2017 - Sensitive in vivo Visualization of Breast Cancer Using Ratiometric Protease-activatable Fluorescent Imaging Agent, AVB-620
Theranostics – August 2017
Platform Technology
- Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides
Oral Oncol. – August 2017 - Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice
Otolaryngol Head Neck Surg. – October 2014 - Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides
Cancer Res. – January 2013 - Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation
Angew Chem Int Ed Engl – January 2013 - Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival
Proc Natl Acad Sci U.S.A – March 2010 - Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases
Proc Natl Acad Sci U.S.A – March 2010 - In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer
Integr Biol (Camb) – June 2009 - Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides
Integr Biol (Camb) – June 2009 - Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Proc Natl Acad Sci U.S.A – December 2004